With the FDA clearance of an investigational new drug application for SynKIR-310, a phase 1 trial evaluating the agent in ...
In an interview with Targeted Oncology for Brain Cancer Awareness Month, Theodore Schwartz, MD, discussed the challenges of ...
During a Case-Based Roundtable® event, Jonathan L. Kaufman, MD, discussed which lines of therapy and at what doses would be ...
Ira Zackon, MD, discusses the results of a real-world study evaluating racial and socioeconomic disparities among patients with chronic lymphocytic leukemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results